2.25
Maxcyte Inc (MXCT) 最新ニュース
What makes MaxCyte Inc. stock price move sharplyBig Profit Small Risk Alerts - Newser
How MaxCyte Inc. stock performs during market volatilitySmart High Yield Swing Trades - Metal.it
What drives MaxCyte Inc. stock priceHigh-yield investments - PrintWeekIndia
What makes MaxCyte Inc. stock attractive to long term investorsRapid growth trajectories - jammulinksnews.com
Is MaxCyte Inc. a good long term investmentHigh-return market picks - PrintWeekIndia
What analysts say about MaxCyte Inc. stockRapid portfolio appreciation - Autocar Professional
MaxCyte Inc. Stock Analysis and ForecastSuperior risk-adjusted returns - Autocar Professional
Published on: 2025-07-23 21:52:41 - Autocar Professional
Why MaxCyte Inc. stock attracts strong analyst attentionHigh Potential Stock Ideas - Newser
IWN ETF Implied Analyst Target Price: $198.15 - AInvest
MaxCyte to Report Second Quarter 2025 Financial Results on August 6, 2025 - 富途牛牛
MaxCyte, Inc. to Release Second Quarter 2025 Financial Results on August 6th - Nasdaq
PHC announces exclusive distribution of MaxCyte ExPERT platform in Japan - BioSpectrum Asia
PHC TO EXCLUSIVELY DISTRIBUTE MAXCYTE CELL ENGINEERING PLATFORM IN JAPAN - bernama
Business Wire - JIJI PRESS
PHC Announces Exclusive Distribution of MaxCyte® ExPERT™ Platform in Japan - Business Wire
MaxCyte Cancels AIM Market Trading for Common Stock - TipRanks
MaxCyte to delist shares from London AIM, maintains Nasdaq listing - Investing.com
Moving Gene Editing Advances Into the Clinic - the-scientist.com
大文字化:
|
ボリューム (24 時間):